BAC vs MRK: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Bank of America Corporation · Financial Services
$52.54
+7.3% upside to fair value
Grade B+
VS
Merck & Co., Inc. · Healthcare
$121.42
-2.9% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
BAC has more upside to fair value
(+7.3%).
BAC trades at a lower forward P/E
(12.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BAC |
MRK |
| Current Price |
$52.54 |
$121.42 |
| Fair Value Estimate |
$56.39 |
$118.00 |
| Upside to Fair Value |
+7.3%
|
-2.9%
|
| Market Cap |
$377.1B |
$300.2B |
| Forward P/E |
12.1x
|
14.0x
|
| EV / EBITDA |
12.8x
|
11.8x
|
| Price / Sales |
2.0x
|
4.1x
|
| Price / FCF |
29.9x
|
21.4x
|
| Revenue Growth YoY |
-0.5%
|
+1.3%
|
| Gross Margin |
56.1%
|
81.5%
|
| Operating Margin |
19.7%
|
41.2%
|
| Return on Equity |
10.1%
|
34.7%
|
| Dividend Yield |
2.09% |
3.1% |
| FCF Yield |
3.35%
|
4.7%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Bank of America is a top-two U.S. bank by assets with $3.4 trillion on its balance sheet, generating $30.5 billion in net income in 2025 on the back of 12.5% earnings growth. The bank benefits from scale in consumer deposits, a recovering investment banking franchise, and an expanding digital platform serving 47 million active users. At 12.7x trailing earnings and 1.97x sales, BAC trades at a fai…
Merck is a top-5 global pharmaceutical company generating $65B in annual revenue with 81.5% gross margins and 28% net margins. Keytruda, the world's best-selling drug at $31.7B (49% of pharma revenue), faces patent expiry in 2028. Merck is aggressively building replacements through M&A and pipeline launches: Winrevair ($1.4B year one), Capvaxive ($759M), and the $6.7B Terns acquisition for TERN-7…
Accumulation Zones
| Metric |
BAC |
MRK |
| Zone Low |
$42.29 |
$88.00 |
| Zone High |
$47.93 |
$100.00 |
| In Buy Zone? |
No
|
No
|